Hims Stock Tumbles As FDA Targets Its Discounted Weight-Loss Drugs

The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug’s ingredients and referring the company to the Department of Justice for potential violations of federal law. Federal action to limit the production of compounded drugs ...